ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,873, issued on Aug. 25, was assigned to BroadenBio Co. Ltd. (Beijing).
"Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof" was invented by Gongping Duan (Beijing), Xingmin Zhang (Beijing), Zhihua Wang (Beijing), Xianglong Wei (Beijing) and Min Li (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in the present application are a compound represented by formula (I), a pharmaceutical composition containing the compound, and the use thereof. The compound represented by formula (I) of the present application has a good effect in terms of inhibiting the activity of HPK1."
The patent was filed on Nov. 3, 2021, un...